![Néstor A. Molfino](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Néstor A. Molfino is a former Chief Executive Officer at Pulmotect, Inc. He also worked as a Director of Clinical Research at Abbott Laboratories.
Prior to that, he held the position of Director of Medical Affairs at Baxter BioScience Corp.
In addition, he served as the Senior Director of Clinical Development at Otsuka Maryland Research Institute, Inc. and as the Vice President of Clinical Development at MedImmune LLC.
He was also the Vice President of Research & Development at Theratechnologies, Inc. Dr. Molfino's former job at Humanigen, Inc. was Chief Medical Officer.
He also worked as a Principal at Boehringer Ingelheim Corp.Dr. Molfino obtained a doctorate degree from the National University of Rosario.
He also completed a graduate degree at Mount Sinai Research Institute.
Anciens postes connus de Néstor A. Molfino
| Sociétés | Poste | Fin |
|---|---|---|
Pulmotect, Inc.
 Pulmotect, Inc. BiotechnologyHealth Technology Develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections | Directeur Général | 30/09/2019 |
| HUMANIGEN, INC. | Directeur Technique/Scientifique/R&D | 03/02/2015 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | 01/01/2012 |
Otsuka Pharmaceutical Development & Commercialization, Inc.
 Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Corporate Officer/Principal | 01/01/2008 |
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Corporate Officer/Principal | 01/01/2003 |
Formation de Néstor A. Molfino
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
38
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Theratechnologies, Inc.
 Theratechnologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty pharmaceutical company that discovers and develops innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides | Health Technology |
Humanigen, Inc.
 Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Health Technology |
National University of Rosario
 National University of Rosario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Health Technology |
Mount Sinai Research Institute
 Mount Sinai Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pulmotect, Inc.
Pulmotect, Inc. BiotechnologyHealth Technology Develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections | Health Technology |
